SEC Form 4 · accession 0001140361-15-043448
OncoMed Pharmaceuticals Inc · OMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurence Lasky
Director
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2015 | J | 7,433 | $0.00 | A | 10,332 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person received the shares for no consideration as part of a pro-rata distribution of shares by certain funds associated with Latterell Venture Partners.